Seema Dawood: Microscopic Findings, Pathophysiology and Associated Conditions of Thrombophagocytosis
Seema Dawood, Medical Laboratory Technologist at The Aga Khan University Hospital, shared a post on LinkedIn:
“Thrombophagocytosis
Thrombophagocytosis is a phenomenon in which white blood cells – most commonly Monocytes or Macrophages (histiocytes) – engulf platelets within their cytoplasm.
Microscopic Findings
- Platelets are observed inside the cytoplasm of macrophages or histiocytes
- Commonly associated with thrombocytopenia (low platelet count)
Pathophysiology:
Thrombophagocytosis results from severe immune system activation, leading to excessive macrophage activation.
Activated macrophages abnormally phagocytose blood cells, including platelets.
Associated Conditions
- Hemophagocytic lymphohistiocytosis (HLH) – most common and clinically significant
- Severe infections (e.g., Dengue fever, EBV, CMV, sepsis)
- Autoimmune diseases (e.g., systemic lupus erythematosus; SLE)
- Certain Hematologic malignancies
Represents a marker of severe immune activation
When found together with:
- Thrombocytopenia
- Multilineage cytopenia
- Persistent fever and hepatosplenomegaly
HLH should be strongly suspected, and further evaluation is urgently required.
HLH and Thrombophagocytosis
Hemophagocytic lymphohistiocytosis (HLH) is a disorder characterized by uncontrolled and severe immune activation.
It results from impaired function of NK cells and cytotoxic T lymphocytes, leading to:
- Failure to regulate immune responses
- Persistent activation of macrophages
- In HLH, macrophage activation is excessive and sustained
Activated macrophages perform hemophagocytosis, engulfing various blood cells:
- Platelets – Thrombophagocytosis
- Red blood cells – Erythrophagocytosis
- White blood cells – Leukophagocytosis
Therefore, thrombophagocytosis is one of the characteristic morphologic findings in HLH and supports the diagnosis when correlated with clinical and laboratory features.”
Other posts featuring Seema Dawood on Hemostasis Today.
-
Aug 13, 2026, 10:31Brad Wilson: Clinical Insights from the Landmark ESC 2026 Trials
-
Aug 13, 2026, 10:23Rania Baleela: Evaluating Bedside Diagnostics and VICC Outcomes in Hemotoxic Snakebite
-
Aug 13, 2026, 10:11Christina Kounoudi: Low-Dose vs. Therapeutic Anticoagulation in Extended VTE Prophylaxis
-
Aug 13, 2026, 10:10Jean Connors: Can Prothrombin Levels Improve Antiphospholipid Syndrome Risk Assessment?
-
Aug 13, 2026, 09:44Edward Lee Carter: Why Clinically Relevant Nonmajor Bleeding Demands Anticoagulation Stewardship?
-
Aug 13, 2026, 09:40Neel Bhut: Can AI Help Us Make Gene Therapy More Efficient?
-
Aug 13, 2026, 08:23Sally Mandour: The Diagnostic Challenge of Hypocellular Bone Marrow Failure
-
Aug 13, 2026, 08:11Cristiana Coneru: How the Gut Microbiome Influences Venous Thrombosis
-
Aug 13, 2026, 06:36Steffen Uffenorde: Improving Access to Automated Red Cell Exchange in SCD